Breast cancer jab 'prevents the disease in 75% of cases': Treatment could spare thousands of women the trauma of surgery
The main beneficiaries of the jab developed in the U.S. are likely to be women with a very early form of breast cancer called ductal carcinoma in situ, or DCIS.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Health | Women